Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03115177Completed
Randomised, open-label trial of doxycycline in Cutibacterium acnes infection (2 arms), sponsored by Rush University Medical Center. Primary endpoint: Presence of Propionibacterium acnes in Bacterial Culture at 2 weeks. Started Nov 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03115177.